Pulmonx Statistics
Total Valuation
Pulmonx has a market cap or net worth of $244.70 million. The enterprise value is $213.88 million.
Important Dates
The last earnings date was Wednesday, October 30, 2024, after market close.
Earnings Date | Oct 30, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Pulmonx has 39.15 million shares outstanding. The number of shares has increased by 2.88% in one year.
Shares Outstanding | 39.15M |
Shares Change (YoY) | +2.88% |
Shares Change (QoQ) | +0.86% |
Owned by Insiders (%) | 4.26% |
Owned by Institutions (%) | 89.46% |
Float | 37.48M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.32 |
Forward PS | 2.88 |
PB Ratio | 2.84 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.70 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.70, with a Debt / Equity ratio of 0.59.
Current Ratio | 7.70 |
Quick Ratio | 6.53 |
Debt / Equity | 0.59 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -16.30 |
Financial Efficiency
Return on equity (ROE) is -51.99% and return on invested capital (ROIC) is -22.90%.
Return on Equity (ROE) | -51.99% |
Return on Assets (ROA) | -20.65% |
Return on Capital (ROIC) | -22.90% |
Revenue Per Employee | $284,237 |
Profits Per Employee | -$204,685 |
Employee Count | 279 |
Asset Turnover | 0.45 |
Inventory Turnover | 1.24 |
Taxes
In the past 12 months, Pulmonx has paid $710,000 in taxes.
Income Tax | 710,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.79% in the last 52 weeks. The beta is 0.64, so Pulmonx's price volatility has been lower than the market average.
Beta (5Y) | 0.64 |
52-Week Price Change | -20.79% |
50-Day Moving Average | 7.26 |
200-Day Moving Average | 8.39 |
Relative Strength Index (RSI) | 40.82 |
Average Volume (20 Days) | 209,043 |
Short Selling Information
The latest short interest is 1.78 million, so 4.55% of the outstanding shares have been sold short.
Short Interest | 1.78M |
Short Previous Month | 1.68M |
Short % of Shares Out | 4.55% |
Short % of Float | 4.75% |
Short Ratio (days to cover) | 8.38 |
Income Statement
In the last 12 months, Pulmonx had revenue of $79.30 million and -$57.11 million in losses. Loss per share was -$1.47.
Revenue | 79.30M |
Gross Profit | 58.81M |
Operating Income | -58.21M |
Pretax Income | -57.29M |
Net Income | -57.11M |
EBITDA | -54.32M |
EBIT | -58.21M |
Loss Per Share | -$1.47 |
Full Income Statement Balance Sheet
The company has $107.78 million in cash and $55.81 million in debt, giving a net cash position of $51.97 million or $1.33 per share.
Cash & Cash Equivalents | 107.78M |
Total Debt | 55.81M |
Net Cash | 51.97M |
Net Cash Per Share | $1.33 |
Equity (Book Value) | 93.93M |
Book Value Per Share | 2.39 |
Working Capital | 122.63M |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 74.16%, with operating and profit margins of -73.40% and -72.01%.
Gross Margin | 74.16% |
Operating Margin | -73.40% |
Pretax Margin | -71.12% |
Profit Margin | -72.01% |
EBITDA Margin | -68.50% |
EBIT Margin | -73.40% |
FCF Margin | -46.14% |